Global Biosimilars Market Report By Product (Insulin,Recombinant human growth hormone (rhGH),Granulocyte colony-stimulating factor,Interferon,Erythropoietin,Etanercept,Monoclonal antibodies( Rituximab, Infliximab, Adalimumab, Trastuzumab and Other Monoclonal Antibodies) ,Follitropin,Glucagon,Calcitonin,Teriparatide,Enoxaparin Sodium), By Type of Manufacturing (In-House Manufacturing,Contract Manufacturing), By Indication (Offsite Treatment,Oncology,Chronic Disorder,Autoimmune Disease,Blood Disorders,Infectious Disease,Other Diseases) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2020-2027

ID:VMR11213892
December 2020
Report Formats:
The global demand for Biosimilars Market is presumed to reach the valuation of nearly USD XX MN by 2027 from USD XX MN in 2020 with a CAGR of XX% under the study period of 2020 - 2027. 

A biosimilar is defined as a biologic medical product extremely similar to another already approved biological medication. Biosimilars are not generic drugs, but they are highly similar to originator biologic agents. The primary benefit of Biosimilars is less expensive as compared to the originators. Biosimilars are permitted as per the same standards of pharmaceutical quality, efficacy, and safety that are valid to all biological medicines. Biosimilars also have considerably higher research and development costs and risks and are more complicated to manufacture than small-molecule generics. Biosimilars have the prospective to give additional treatment options at a lesser price, but its development requires substantial investment.

Market Dynamics

The rising prevalence of chronic diseases and the high demand for biosimilars due to their cost-effectiveness are the primary factors driving the biosimilars market. The increasing collaborations for biosimilar research and clinical trials and strong product pipeline contribute to the biosimilars market's growth. The growing geriatric population and the patent expiry of biologic products are positively impacting the biosimilars market's growth. Moreover, the recent biosimilar product approvals in major countries and the rising number of product launches that will drive market growth is likely to create beneficial growth opportunities for key players of the biosimilars market in the coming years.

The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.

Additionally, these tools also give inclusive assessment of each segment in the global market of biosimilars.

Market Segmentation

This section of the biosimilars market report  provides detailed data on the segments by analyzing them geographically, thereby assisting the strategist in identifying the target demographics for the respective product or service.

By Product
  • Insulin
  • Recombinant human growth hormone (rhGH)
  • Granulocyte colony-stimulating factor
  • Interferon
  • Erythropoietin
  • Etanercept
  • Monoclonal antibodies( Rituximab, Infliximab, Adalimumab, Trastuzumab and Other Monoclonal Antibodies) 
  • Follitropin
  • Glucagon
  • Calcitonin
  • Teriparatide
  • Enoxaparin Sodium

By Type of Manufacturing
  • In-House Manufacturing
  • Contract Manufacturing 

By Indication
  • Offsite Treatment
  • Oncology
  • Chronic Disorder
  • Autoimmune Disease
  • Blood Disorders
  • Infectious Disease
  • Other Diseases

Regional Analysis

This section covers regional segmentation which accentuates on current and future demand for Biosimilars market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.

Europe Biosimilars Market by Revenue (USD MN)



The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the biosimilars market include Zydus Cadila , Amgen, 3SBio, Biogen, Biocon, Boehringer Ingelheim, Coherus BioSciences, Elli Lilly and Company, , Celltrion, Intas Biopharmaceuticals, Lupin, Dr. Reddy's Laboratories, Merck, Novartis (Sandoz), Ratiopharm, Samsung Bioepis, Sanofi, STADA Arzneimittel, Teva Pharmaceutical, Wockhardt.S. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
 
METHODOLOGY:

This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources,  Technical Journals, Financial Reports, SEC Filings, and other different industry publications. 

If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Market
       2.2. Global Market Snapshot
 
3 . BIOSIMILARS – INDUSTRY ANALYSIS
       3.1. Introduction - Market Dynamics
       3.2. Market Drivers
       3.3. Market Restraints
       3.4. Opportunities
       3.5. Industry Trends
       3.6. Porter’s Five Force Analysis
       3.7. Market Attractiveness Analysis
           3.7.1 By Product
           3.7.2 By Type of Manufacturing
           3.7.3 By Indication
           3.7.4 By Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Value Chain Analysis
       4.2. Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Raw Material Manufactures List
           4.2.3. Price Trend of Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
       5.5. COVID-19: Micro and Macro Factor Analysis
 
6 . GLOBAL BIOSIMILARS MARKET ANALYSIS BY PRODUCT
       6.1 Overview by Product
       6.2 Historical and Forecast Data
       6.3 Analysis by Product
       6.4 Insulin Market by Regions
       6.6 Recombinant human growth hormone (rhGH) Market by Regions
       6.5 Granulocyte colony-stimulating factor Market by Regions
       6.7 Interferon Market by Regions
       6.8 Erythropoietin Market by Regions
       6.9 Etanercept Market by Regions
       6.10. Monoclonal antibodies  Market by Regions
       6.11 Follitropin Market by Regions
       6.12 Glucagon Market by Regions
       6.13 Calcitonin Market by Regions
       6.14 Teriparatide Market by Regions
 
7 . GLOBAL BIOSIMILARS MARKET ANALYSIS BY TYPE OF MANUFACTURING
       7.1 Overview by Type of Manufacturing
       7.2 Historical and Forecast Data
       7.3 Analysis by Type of Manufacturing
       7.4 In-House Manufacturing Market by Regions
       7.5 Contract Manufacturing  Market by Regions
 
8 . GLOBAL BIOSIMILARS MARKET ANALYSIS BY INDICATION
       8.1 Overview by Indication
       8.2 Historical and Forecast Data
       8.3 Analysis by Indication
       8.4 Offsite Treatment Market by Regions
       8.5 Oncology Market by Regions
       8.6 Chronic Disorder Market by Regions
       8.7 Autoimmune Disease Market by Regions
       8.8 Blood Disorders Market by Regions
       8.9 Infectious Disease Market by Regions
       8.10. Other Diseases Market by Regions
 
9 . GLOBAL BIOSIMILARS MARKET ANALYSIS BY GEOGRAPHY
       9.1. Regional Outlook
       9.2. Introduction
       9.3. North America
           9.3.1. Overview, Historic and Forecast Data
           9.3.2. North America By Segment
           9.3.3. North America By Country
           9.3.4. United State
           9.3.5. Canada
           9.3.6. Mexico
       9.4. Europe
           9.4.1. Overview, Historic and Forecast Data
           9.4.2. Europe by Segment
           9.4.3. Europe by Country
           9.4.4. United Kingdom
           9.4.5. France
           9.4.6. Germany
           9.4.7. Italy
           9.4.8. Russia
           9.4.9. Rest Of Europe
       9.5. Asia Pacific
           9.5.1. Overview, Historic and Forecast Data
           9.5.2. Asia Pacific by Segment
           9.5.3. Asia Pacific by Country
           9.5.4. China
           9.5.5. India
           9.5.6. Japan
           9.5.7. South Korea
           9.5.8. Australia
           9.5.9. Rest Of Asia Pacific
       9.6. Latin America
           9.6.1. Overview, Historic and Forecast Data
           9.6.2. Latin America by Segment
           9.6.3. Latin America by Country
           9.6.4. Brazil
           9.6.5. Argentina
           9.6.6. Peru
           9.6.7. Chile
           9.6.8. Rest of Latin America
       9.7. Middle East & Africa
           9.7.1. Overview, Historic and Forecast Data
           9.7.2. Middle East & Africa by Segment
           9.7.3. Middle East & Africa by Country
           9.7.4. Saudi Arabia
           9.7.5. UAE
           9.7.6. Israel
           9.7.7. South Africa
           9.7.8. Rest Of Middle East And Africa
 
10 . COMPETITIVE LANDSCAPE OF THE BIOSIMILARS COMPANIES
       10.1. Biosimilars Market Competition
       10.2. Partnership/Collaboration/Agreement
       10.3. Merger And Acquisitions
       10.4. New Product Launch
       10.5. Other Developments
 
11 . COMPANY PROFILES OF BIOSIMILARS INDUSTRY
       11.1. Company Share Analysis
       11.2. Market Concentration Rate
       11.3. Zydus Cadila
           11.3.1. Company Overview
           11.3.2. Financials
           11.3.3. Products
           11.3.4. Recent Developments
       11.4. Amgen
           11.4.1. Company Overview
           11.4.2. Financials
           11.4.3. Products
           11.4.4. Recent Developments
       11.5. 3SBio
           11.5.1. Company Overview
           11.5.2. Financials
           11.5.3. Products
           11.5.4. Recent Developments
       11.6. Biogen
           11.6.1. Company Overview
           11.6.2. Financials
           11.6.3. Products
           11.6.4. Recent Developments
       11.7. Biocon
           11.7.1. Company Overview
           11.7.2. Financials
           11.7.3. Products
           11.7.4. Recent Developments
       11.8. Boehringer Ingelheim
           11.8.1. Company Overview
           11.8.2. Financials
           11.8.3. Products
           11.8.4. Recent Developments
       11.9. Coherus BioSciences
           11.9.1. Company Overview
           11.9.2. Financials
           11.9.3. Products
           11.9.4. Recent Developments
       11.10. Elli Lilly and Company
           11.10.1. Company Overview
           11.10.2. Financials
           11.10.3. Products
           11.10.4. Recent Developments
       11.11. Celltrion
           11.11.1. Company Overview
           11.11.2. Financials
           11.11.3. Products
           11.11.4. Recent Developments
       11.12. Intas Biopharmaceuticals
           11.12.1. Company Overview
           11.12.2. Financials
           11.12.3. Products
           11.12.4. Recent Developments
       11.13. Lupin
           11.13.1. Company Overview
           11.13.2. Financials
           11.13.3. Products
           11.13.4. Recent Developments
       11.14. Dr. Reddy's Laboratories
           11.14.1. Company Overview
           11.14.2. Financials
           11.14.3. Products
           11.14.4. Recent Developments
       11.15. Merck
           11.15.1. Company Overview
           11.15.2. Financials
           11.15.3. Products
           11.15.4. Recent Developments
       11.16. Novartis (Sandoz)
           11.16.1. Company Overview
           11.16.2. Financials
           11.16.3. Products
           11.16.4. Recent Developments
       11.17. Ratiopharm
           11.17.1. Company Overview
           11.17.2. Financials
           11.17.3. Products
           11.17.4. Recent Developments
       11.18. Samsung Bioepis
           11.18.1. Company Overview
           11.18.2. Financials
           11.18.3. Products
           11.18.4. Recent Developments
       11.19. Sanofi
           11.19.1. Company Overview
           11.19.2. Financials
           11.19.3. Products
           11.19.4. Recent Developments
       11.20. STADA Arzneimittel
           11.20.1. Company Overview
           11.20.2. Financials
           11.20.3. Products
           11.20.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
 LIST OF TABLES
 

  •  Market Snapshot
  •  Drivers : Impact Analysis
  •  Restraints : Impact Analysis
  •  List of Raw Material
  •  List of Raw Material Manufactures
  •  List of Potential Buyers
  •  COVID-19 Impact Analysis by Production, Import, Export and Demand
  •  Pre V/S Post COVID-19
  •  Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  •  COVID-19: Micro and Macro Factor Analysis
  •  Analysis by Product (USD MN)
  •  Insulin Market by Geography (USD MN)
  •  Recombinant human growth hormone (rhGH) Market by Geography (USD MN)
  •  Granulocyte colony-stimulating factor Market by Geography (USD MN)
  •  Interferon Market by Geography (USD MN)
  •  Erythropoietin Market by Geography (USD MN)
  •  Etanercept Market by Geography (USD MN)
  •  Monoclonal antibodies  Market by Geography (USD MN)
  •  Follitropin Market by Geography (USD MN)
  •  Glucagon Market by Geography (USD MN)
  •  Calcitonin Market by Geography (USD MN)
  •  Teriparatide Market by Geography (USD MN)
  •  Analysis Market by Type of Manufacturing (USD MN)
  •  In-House Manufacturing Market by Geography (USD MN)
  •  Contract Manufacturing  Market by Geography (USD MN)
  •  Analysis by Indication (USD MN)
  •  Offsite Treatment Market by Geography (USD MN)
  •  Oncology Market by Geography (USD MN)
  •  Chronic Disorder Market by Geography (USD MN)
  •  Autoimmune Disease Market by Geography (USD MN)
  •  Blood Disorders Market by Geography (USD MN)
  •  Infectious Disease Market by Geography (USD MN)
  •  Other Diseases Market by Geography (USD MN)
  •  Global Biosimilars Market by Geography (USD MN)
  •  North America Market Analysis (USD MN)
  •  United State Market Analysis (USD MN)
  •  Canada Market Analysis (USD MN)
  •  Mexico Market Analysis (USD MN)
  •  Europe Market Analysis (USD MN)
  •  Europe Market Estimate by Country (USD MN)
  •  United Kingdom Market Analysis (USD MN)
  •  France Market Analysis (USD MN)
  •  Germany Market Analysis (USD MN)
  •  Italy Market Analysis (USD MN)
  •  Russia Market Analysis (USD MN)
  •  Spain Market Analysis (USD MN)
  •  Rest of Europe Market Analysis (USD MN)
  •  Asia Pacific Market Analysis (USD MN)
  •  China Market Analysis (USD MN)
  •  Japan Market Analysis (USD MN)
  •  India Market Analysis (USD MN)
  •  South Korea Market Analysis (USD MN)
  •  Australia Market Analysis (USD MN)
  •  Rest of Asia Pacific Market Analysis (USD MN)
  •  Latin America Market Analysis (USD MN)
  •  Brazil Market Analysis (USD MN)
  •  Argentina Market Analysis (USD MN)
  •  Peru Market Analysis (USD MN)
  •  Chile Market Analysis (USD MN)
  •  Rest of Latin America Market Analysis (USD MN)
  •  Middle East & Africa Market Analysis (USD MN)
  •  Saudi Arabia Market Analysis (USD MN)
  •  UAE Market Analysis (USD MN)
  •  Israel Market Analysis (USD MN)
  •  South Africa Market Analysis (USD MN)
  •  Rest of Middle East and Africa Market Analysis (USD MN)
  •  Partnership/Collaboration/Agreement
  •  Mergers And Acquisiton
 
 LIST OF FIGURES
 
  •  Research Scope of Biosimilars Report
  •  Market Research Process
  •  Market Research Methodology
  •  Global Biosimilars Market Size, by Region (USD MN)
  •  Porters Five Forces Analysis
  •  Market Attractiveness Analysis by Product
  •  Market Attractiveness Analysis by Type of Manufacturing
  •  Market Attractiveness Analysis by Indication
  •  Market Attractiveness Analysis by Region
  •  Value Chain Analysis
  •  Global Market Analysis by Product (USD MN)
  •  Insulin Market by Geography (USD MN)
  •  Recombinant human growth hormone (rhGH) Market by Geography (USD MN)
  •  Granulocyte colony-stimulating factor Market by Geography (USD MN)
  •  Interferon Market by Geography (USD MN)
  •  Erythropoietin Market by Geography (USD MN)
  •  Etanercept Market by Geography (USD MN)
  •  Monoclonal antibodies  Market by Geography (USD MN)
  •  Follitropin Market by Geography (USD MN)
  •  Glucagon Market by Geography (USD MN)
  •  Calcitonin Market by Geography (USD MN)
  •  Teriparatide Market by Geography (USD MN)
  •  Global Market Analysis by Type of Manufacturing (USD MN)
  •  In-House Manufacturing Market by Geography (USD MN)
  •  Contract Manufacturing  Market by Geography (USD MN)
  •  Global Market Analysis by Indication (USD MN)
  •  Offsite Treatment Market by Geography (USD MN)
  •  Oncology Market by Geography (USD MN)
  •  Chronic Disorder Market by Geography (USD MN)
  •  Autoimmune Disease Market by Geography (USD MN)
  •  Blood Disorders Market by Geography (USD MN)
  •  Infectious Disease Market by Geography (USD MN)
  •  Other Diseases Market by Geography (USD MN)
  •  Global Market by Revenue
  •  North America Market by Revenue
  •  Europe Market by Revenue
  •  Asia Pacific Market by Revenue
  •  Latin America Market by Revenue
  •  Middle East & Africa Market by Revenue
  •  Recent Development in Industry
  •  Company Market Share Analysis, 2020
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials